You may also like
Genes Released From Coated Stents Could Reduce Coronary Artery Restenosis Rates
WESTPORT, CT (Reuters Health) – Localized delivery of genes from coronary artery stents could reduce the risk of restenosis, according to a […]
1 min read
The Risk Associated with Aprotinin in Cardiac Surgery
In this observational study involving 4374 patients undergoing revascularization, we prospectively assessed three agents (aprotinin [1295 patients], aminocaproic acid [883], and tranexamic acid [822]) as compared with no agent (1374 patients) with regard to serious outcomes by propensity and multivariable methods.
1 min read
Plasma-Modified ACT Can Be Used to Monitor Bivalirudin (Angiomax) Anticoagulation for On-Pump Cardiopulmonary Bypass Surgery in a Patient with Heparin-Induced Thrombocytopenia
We report here the successful use of bivalirudin anticoagulation on pump, with no additional morbidity, and the first reported use of the plasma-modified ACT (activated clotting time) test, a simple modification of the standard ACT assay, to monitor the anticoagulant effect of bivalirudin.
1 min read